Phosphatidylserine (PS) — Supplements
FDA-qualified health claim for cognitive decline; reduces exercise-induced cortisol by 20-30%; 6 RCTs in MCI/Alzheimer's showing memory and cognitive speed improvement.
Overview
Phosphatidylserine (PS) is an essential phospholipid that constitutes approximately 15% of total brain lipid mass and is highly enriched in neuronal cell membranes — particularly in the inner leaflet of the plasma membrane where it modulates signal transduction. PS is naturally derived from bovine brain (originally used in early RCTs) or soy/sunflower lecithin (current dietary supplement form, to avoid BSE concerns). It holds one of the very few FDA-qualified health claims for cognitive decline. Three principal mechanisms drive its clinical effects: PS is the rate-limiting substrate for phosphatidylcholine synthesis via the Lands cycle, supports HPA axis regulation by blunting ACTH and cortisol release, and maintains dopaminergic and cholinergic receptor density. A 1991 multicenter double-blind RCT (Crook et al., Neurology, n=149, 12 weeks) established significant improvement in memory tasks in subjects with age-associated memory impairment. A 1992 Alzheimer's disease RCT (Amaducci, Psychopharmacology Bulletin) showed significant improvements on global scales. A 2010 meta-analysis of 6 RCTs confirmed benefit for memory and cognitive speed in elderly subjects with memory complaints. In athletes, PS supplementation (600–800 mg/day) significantly reduces post-exercise cortisol and ACTH responses — improving recovery and reducing perceived exertion.
Indications
- Age-associated memory impairment and mild cognitive impairment
- Athletic recovery — cortisol reduction and overtraining prevention
- ADHD (emerging evidence in children and adults)
- Stress and HPA axis dysregulation
- Cognitive performance under stress
Mechanism of Action
PS maintains the structural integrity and fluidity of neuronal plasma membranes, supporting optimal density and conformation of acetylcholine, dopamine, and NMDA receptors. Age-related PS depletion from neuronal membranes is associated with loss of receptor sensitivity and impaired signal transduction
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Phosphatidylserine (soy-derived) | 100 mg | Three times daily with meals (300 mg total) | 100 mg TID is the most common clinical dose; athletic cortisol-reduction protocols use 400–800 mg/day total |
| Phosphatidylserine (athletic protocol) | 400–800 mg | Once daily, pre-exercise or with morning meal | Higher doses used in exercise cortisol studies; 800 mg/day showed >20% cortisol reduction in elite athletes |
Safety & Contraindications
- Excellent safety profile — well tolerated at 300–800 mg/day in all clinical trials
- Most common side effects: mild GI upset (insomnia reported rarely at high doses)
- Soy-derived PS is the standard commercial form — contraindicated in severe soy allergy
- Potential blood-thinning effect — use caution with anticoagulants (theoretical, limited clinical evidence)
- Bovine brain-derived PS (used in original RCTs) is no longer commercially available due to BSE concerns; soy-derived PS may have somewhat different bioavailability
- No significant drug interactions at standard doses